No Data
No Data
Guangzheng Eye Hospital Group: 2024 Interim Performance Forecast
Guangzheng Eye Hospital Group Co.,Ltd.'s (SZSE:002524) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Shareholders in Guangzheng Eye Hospital GroupLtd (SZSE:002524) Have Lost 77%, as Stock Drops 19% This Past Week
Guangzheng Ophthalmology (002524.SZ): Currently, no visual prevention and control products have been developed and produced
Gelonghui, March 29丨An investor asked Guangzheng Ophthalmology (002524.SZ) on the investor interactive platform. Regarding “whether your company researches and produces myopia prevention and control products,” the company replied that the company has not yet developed and produced vision prevention and control products. The company provides patients with myopia prevention and control diagnosis and treatment services and solutions, and has good cooperative relationships with mainstream myopia prevention and control product suppliers.
Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) 26% Share Price Surge Not Quite Adding Up
Guangzheng Ophthalmology (002524.SZ): 2023 pre-profit of 8 million yuan to 12 million yuan
Ge Longhui, January 29丨Guangzheng Ophthalmology (002524.SZ) announced the 2023 annual performance forecast. Operating income for the reporting period was 1060 million yuan to 1080 million yuan 767.4446 million yuan, up 38.12% to 40.73% over the same period of the previous year; net profit attributable to shareholders of listed companies was 8 million yuan to 12 million yuan, or -78.1776 million yuan in the same period last year; net profit after deducting non-recurring profit and loss was -4 million yuan to -2 million yuan, compared to -291.681 million yuan for the same period last year; basic per share Earnings of 0.02 yuan to 0.
No Data